« Previous
Next »
American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 2
, Pages 73-77
, March 2007
Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy
References
- . Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer. 2001;92:556–568
- Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999;5:1369–1379
- Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg. 1997;174:513–517
- The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients. Respir Med. 2004;98:632–636
- Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. Cancer. 2004;100:270–278
- . Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2002;31:495–498
- . Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance. Ann Otol Rhinol Laryngol. 2001;110:221–228
- . Functions of the VEGF/VEGF receptor system in the vascular system. Semin Thromb Hemost. 2000;26:553–559
- Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. Oral Oncol. 2000;36:81–88
- . Vascular endothelial growth factor as a target for anticancer therapy. Oncologist. 2004;9:2–10
- Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res. 2002;62:7042–7049
- Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell. 1998;9:875–884
- Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma. Clin Otolaryngol. 1999;24:426–430
- Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. Anticancer Res. 2004;24:1149–1158
- Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancer. Strahlenther Onkol. 2001;177:469–473
- Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Cancer Res. 1996;2:821–826
- Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer. 1997;76:238–243
- Serum levels of vascular endothelial growth factor in patients with head and neck cancer. Eur Arch Otorhinolaryngol. 2000;257:332–336
- Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999;5:1369–1379
- . Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control. 2002;9:6–44
- . Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2002;31:495–498
- The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. Cancer Lett. 2003;192:215–225
- Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer. Acta Oncol. 2003;42:837–845
- Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer. Breast Cancer. 2003;10:120–128
- Serum vascular endothelial growth factor levels in pancreatic cancer patients with advanced and metastatic disease and poor prognosis. Cancer Lett. 2003;194:119–124
- Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase–2 in advanced carcinomas of the head and neck. HNO. 1999;47:695–701
PII: S0196-0709(06)00123-2
doi: 10.1016/j.amjoto.2006.06.015
« Previous
Next »
American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 2
, Pages 73-77
, March 2007
